clarithromycin has been researched along with Catheter-Associated Infections in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cañas-Hernandez, F; de Miguel-Martinez, I; Lorenzo-Garde, L | 1 |
| Aberrane, S; Frija-Masson, J; Housset, B; Jabot, L; Mangiapan, G; Monnet, I | 1 |
| Antony, SJ | 1 |
| Adderson, EE; Apiwattankul, N; Flynn, PM; Hayden, RT | 1 |
1 review(s) available for clarithromycin and Catheter-Associated Infections
| Article | Year |
|---|---|
Infections Caused by Rapidly Growing Mycobacteria spp in Children and Adolescents With Cancer.
Topics: Adolescent; Amikacin; Anti-Infective Agents; Catheter-Related Infections; Child; Child, Preschool; Clarithromycin; Debridement; Female; Humans; Immunocompromised Host; Infant; Lung Diseases; Male; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium Infections; Neoplasms; Retrospective Studies | 2015 |
3 other study(ies) available for clarithromycin and Catheter-Associated Infections
| Article | Year |
|---|---|
[Bacteriemia due to Mycobacterium canariasense in an oncohematological patient with a long-term central device].
Topics: Aged; Bacteremia; Bacterial Typing Techniques; Catheter-Related Infections; Catheterization, Central Venous; Ciprofloxacin; Clarithromycin; Humans; Lymphoma, Non-Hodgkin; Male; Mycobacterium; Mycobacterium Infections | 2014 |
[Non-tuberculous mycobacterial infection of a totally implanted perfusion device].
Topics: Administration, Oral; Anti-Bacterial Agents; Antineoplastic Agents; Catheter-Related Infections; Clarithromycin; Cross Infection; Female; Humans; Infusions, Intravenous; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous | 2015 |
Catheter related line sepsis resulting from Mycobacterium chelonae infection in an immunocompromised host.
Topics: Adult; Catheter-Related Infections; Ciprofloxacin; Clarithromycin; Cross Infection; Drug Therapy, Combination; Female; Humans; Immunocompromised Host; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Ovarian Neoplasms; Sepsis; Vascular Access Devices | 2015 |